These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14651407)

  • 1. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney.
    Day C; White B; Ross J; Dolan K
    Aust N Z J Public Health; 2003 Oct; 27(5):558. PubMed ID: 14651407
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
    N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination and injecting drug users.
    Budd J; Robertson R; Elton R
    Br J Gen Pract; 2004 Jun; 54(503):444-7. PubMed ID: 15186567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccination and injecting drug use: narrowing the efficacy-effectiveness gap.
    Maher L
    Int J Drug Policy; 2008 Dec; 19(6):425-8. PubMed ID: 18289840
    [No Abstract]   [Full Text] [Related]  

  • 6. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia.
    Rhodes T; Zikic B; Prodanović A; Kuneski E; Bernays S
    Soc Sci Med; 2008 Mar; 66(6):1437-47. PubMed ID: 18201809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis vaccination among drug users.
    Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
    Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis B and C risk factors in Germany--results of the national surveillance].
    Walter J; Radun D; Claus H; Hamouda O; Stark K
    Gesundheitswesen; 2005 Jul; 67(7):441-7. PubMed ID: 16103966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
    Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
    Ellard J
    Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
    Baklan Z; Gorisek JR; Poljak M; Pisec A
    Wien Klin Wochenschr; 2004; 116 Suppl 2():5-7. PubMed ID: 15506302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of injecting drug users' self report of hepatitis A, B, and C.
    Schlicting EG; Johnson ME; Brems C; Wells RS; Fisher DG; Reynolds G
    Clin Lab Sci; 2003; 16(2):99-106. PubMed ID: 12757189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B immunity in a population of drug and alcohol users.
    Polizzotto MN; Whelan G
    Drug Alcohol Rev; 2007 Jul; 26(4):417-9. PubMed ID: 17564878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Knowledge about hepatitis B and C viruses and HIV among blood donors in Casablanca].
    Boutayeb H; Aamoum A; Benchemsi N
    East Mediterr Health J; 2006 Sep; 12(5):538-47. PubMed ID: 17333791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
    Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'It's your life!': injecting drug users, individual responsibility and hepatitis C prevention.
    Fraser S
    Health (London); 2004 Apr; 8(2):199-221. PubMed ID: 15068637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.